Clinical Trial Update: Corifollitropin Alfa Compared to Daily rFSH in Poor Responders Undergoing ICSI [Phase 4]

View source ↗

Summary

A Phase 4 trial comparing corifollitropin alfa to daily recombinant FSH in poor responders undergoing an ICSI cycle has been completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Infertility

Drugs mentioned

• Corifollitropin alfa (Corifollitropin alfa)
• Follitropin alfa (folitropin alfa)

Snippet

Sponsor: Aristotle University Of Thessaloniki | Conditions: Subfertility | Phase 4 | Status: COMPLETED